This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Arthur J. Gallagher Buys Doyle Group, Boosts Affinity Business
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of The Doyle Group to its portfolio will help enhance its Gallagher Affinity operations.
Brown & Brown's (BRO) Unit Acquires Poole Professional
by Zacks Equity Research
Brown & Brown (BRO) takes the inorganic route to achieve growth and leverage its risk management solutions.
5 Insurance Stocks Poised to Beat Q3 Earnings Estimates
by Tanuka De
We have identified five insurers poised to outshine in the third quarter banking on solid fundamentals.
Arthur J. Gallagher's Latest Buyout to Aid in Cross Selling
by Zacks Equity Research
Arthur J. Gallagher (AJG) takes the inorganic route to expand its presence and make the most of cross- selling opportunities.
Marsh & McLennan's Unit Ties Up for Pet Insurance Program
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Marsh partners Zurich North America to launch a pet insurance program.
Arthur J. Gallagher to Acquire Michigan-Based LSG Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) agrees to purchase LSG Insurance Partners to boost its consulting operations.
Marsh & McLennan, Xevant Tie Up to Ease Employer Assistance
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary collaborates with Xevant to offer a strategic optimization solution for employer-funded pharmacy benefit plans.
Arthur J. Gallagher (AJG) Buys Ohio-Based Andrew Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) takes the inorganic route to improve and expand the insurance business.
Arthur J. Gallagher's Allied Insurance Buyout to Drive Growth
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Allied Insurance Brokers to boost its insurance management.
Marsh & McLennan's Unit Joins Next Peak for Cyber Protection
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary Oliver Wyman teams up with Next Peak to safeguard against cyber risks.
Arthur J. Gallagher Acquires Serna to Boost Personal Lines
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) takes the inorganic route to improve its business in personal lines and commercial insurance products
eHealth Enters Oversold Territory
by Zacks Equity Research
eHealth has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Marsh & McLennan Inks Deal With Construction Risk Partners
by Zacks Equity Research
Marsh & McLennan (MMC) reaches an agreement with Construction Risk Partners, according to which the latter will buy the company's stock from JLT.
Is eHealth (EHTH) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
Why You Should Keep Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Banking on strategic acquisitions and financial flexibility, Marsh & McLennan (MMC) holds enough potential to reap benefits for investors.
Arthur J. Gallagher Buys California-Based Garnett-Powers
by Zacks Equity Research
Arthur J. Gallagher's (AJG) acquisition of Garnett-Powers is a strategic fit as it will help ramp up its higher education practice.
eHealth (EHTH) Rallies 165% YTD: Will the Upside Continue?
by Zacks Equity Research
eHealth's (EHTH) operational excellence and growth initiatives help the stock continue the bull run.
Brown & Brown Acquires WBR Insurance, Expands in Virginia
by Zacks Equity Research
Brown & Brown's (BRO) buyout of WBR Insurance enhances the acquirer's product portfolio and strengthens its presence in Virginia.
eHealth's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in eHealth.
Is eHealth (EHTH) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
EHealth (EHTH) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 124.39% and 72.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
eHealth's (EHTH) Q2 results are likely to benefit from solid performance of its Medicare business.
Earnings Preview: eHealth (EHTH) Q2 Earnings Expected to Decline
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insurance - Brokerage Industry Near-Term Outlook Bright
by Tanuka De
Insurance - Brokerage Industry is poised for growth given growing demand for insurance amid a dynamic and complex business environment.
Aon (AON) Stock Up 37.9% in a Year: Will the Rally Continue?
by Zacks Equity Research
Aon's (AON) inorganic growth profile should favor revenue growth. This will likely perk up its share price further.